Delphia Therapeutics jobs and careers
Cambridge, United States
About Delphia Therapeutics
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.
- Founded
- 2022
- Employees
- 11 to 50
- Total funding
- $67M
- Headquarters
- Cambridge
Leadership
The top of Delphia Therapeutics's org chart, with how many people report into each leader.
KM
Kevin Marks
President & CEO
20 reports
AU
Aimee Usera
Senior Vice President Drug Discovery
15 reports
RM
Reza Mazhari
Chief Business Officer
2 reports
MD
Michael D.
Co-founder
Jobs at Delphia Therapeutics
No open positions right now. Explore more companies on TheJobsMap.